1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ENTERA BIO LTD

Entera Bio Ltd

XNAS: ENTX

Download real time

1.75 -0.05 (-2.78%)

47.76% Fall from 52W High

55,218 XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
8S
14W
3O
0T
64.5

Market Cap

Below industry Median
-7

PE TTM

Negative PE TTM
-0.9

PEG TTM

PEG TTM is negative
10

Price to Book

High in industry
0.3

Beta 1Year

Very Low volatility
Board Meeting
The latest board meeting for Entera Bio Ltd took place on 28 Mar 2025, for the purpose of Entera Bio Ltd Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Entera Bio Ltd

The latest disclosure was made by Haya Taitel in Entera Bio Ltd where a trade of 28,509 Stock Option (right to buy) done was reported to US exchanges on Jan. 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Haya Taitel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 28,509 28,509 - - Stock Option (right to buy)
Haya Taitel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 6,922 64,650 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Sean Ellis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 7,100 134,727 (1%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Sean Ellis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 28,509 28,509 - - Stock Option (right to buy)
Yonatan Malca Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 28,509 28,509 - - Stock Option (right to buy)
Yonatan Malca Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 8,216 47,259 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Gerald M. Ostrov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 28,509 28,509 - - Stock Option (right to buy)
Gerald M. Ostrov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 8,038 46,936 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Haya Taitel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2024 7,278 57,728 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Gerald M. Ostrov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2024 8,452 38,898 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Yonatan Malca Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2024 8,639 39,043 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Sean Ellis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2024 7,466 127,627 (1%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Haya Taitel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 15,335 50,450 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Sean Ellis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 18,061 120,161 (1%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Yonatan Malca Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 23,172 30,404 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Gerald M. Ostrov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 20,446 30,446 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Miranda Jayne Toledano Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2024 124,121 234,873 (2%) 1% 0 Ordinary Shares, par value NIS 0.0000769 per share
Miranda Jayne Toledano Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2024 500,000 500,000 - - Stock Option (Right to Buy)
Dana Yaacov-Garbeli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2024 30,151 86,731 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Dana Yaacov-Garbeli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2024 130,000 130,000 - - Stock Option (right to buy)
Dana Yaacov-Garbeli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2024 30,151 86,731 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Dana Yaacov-Garbeli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2024 130,000 130,000 - - Stock Option (right to buy)
Hillel Galitzer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2024 30,151 64,257 (0%) 0% 0 Ordinary Shares, par value NIS 0.0000769 per share
Hillel Galitzer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2024 130,000 130,000 - - Stock Option (right to buy)
Haya Taitel Director Purchase of securities on an exchange or from another person at price $ 0.99 per share. 12 Jan 2024 9,500 35,115 (0%) 0% 1.0 9,405 Ordinary Shares, par value NIS 0.0000769 per share
Taitel Haya Director Purchase of securities on an exchange or from another person at price $ 0.77 per share. 10 Jan 2024 7,615 25,615 (0%) 0% 0.8 5,864 Ordinary Shares, par value NIS 0.0000769 per share
Ellis Sean Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 108,333 108,333 - - Stock Option (right to buy)
Taitel Haya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 108,333 108,333 - - Stock Option (right to buy)
Ostrov Gerald M. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 108,333 108,333 - - Stock Option (right to buy)
Garceau Roger J. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 108,333 108,333 - - Stock Option (right to buy)
Mayron Ron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 108,333 108,333 - - Stock Option (right to buy)
Malca Yonatan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 108,333 108,333 - - Stock Option (right to buy)
Miranda Toledano Jayne Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Dec 2023 23,952 23,952 - - Warrants (right to buy)
Jayne Toledano Miranda Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.71 per share. 22 Dec 2023 23,952 110,752 (0%) 0% 0.7 17,006 Ordinary Shares, par value NIS 0.0000769 per share
Haya Taitel Director Purchase of securities on an exchange or from another person at price $ 0.62 per share. 22 Aug 2023 18,000 18,000 (0%) 0% 0.6 11,216 Ordinary Shares, par value NIS 0.0000769 per share
Sean Ellis Director Purchase of securities on an exchange or from another person at price $ 0.60 per share. 21 Aug 2023 40,000 102,100 (0%) 0% 0.6 24,000 Ordinary Shares, par value NIS 0.0000769 per share
Dana Yaacov-Garbeli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2023 190,000 190,000 - - Stock Option (right to buy)
Arthur Santora Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2023 35,000 35,000 - - Stock Option (right to buy)
Hillel Galitzer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Apr 2023 210,000 210,000 - - Stock Option (right to buy)
Miranda Jayne Toledano Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.01 per share. 04 Apr 2023 30,000 86,800 (0%) 0% 1.0 30,300 Ordinary Shares, par value NIS 0.0000769 per share
Yonatan Malca Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 89,041 89,041 - - Stock Option (right to buy)
Sean Ellis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 89,041 89,041 - - Stock Option (right to buy
Ron Mayron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 89,041 89,041 - - Stock Option (right to buy)
Gerald M. Ostrov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 89,041 89,041 - - Stock Option (right to buy)
Roger J. Garceau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 89,041 89,041 - - Stock Option (right to buy)
Dana Yaacov-Garbeli Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.54 per share. 11 Nov 2022 26,580 56,580 (0%) 0% 0.5 14,247 Ordinary Shares, par value NIS 0.0000769 per share
Dana Yaacov-Garbeli Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.52 per share. 11 Nov 2022 30,000 30,000 (0%) 0% 0.5 15,600 Ordinary Shares, par value NIS 0.0000769 per share
Sean Ellis Director Purchase of securities on an exchange or from another person at price $ 0.53 per share. 11 Nov 2022 30,000 62,100 (0%) 0% 0.5 15,900 Ordinary Shares, par value NIS 0.0000769 per share
Miranda Jayne Toledano Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.53 per share. 11 Nov 2022 50,000 56,800 (0%) 0% 0.5 26,585 Ordinary Shares, par value NIS 0.0000769 per share
Miranda Jayne Toledano Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Sep 2022 500,000 500,000 - - Stock Option (right to buy)
Miranda Jayne Toledano Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Sep 2022 600,000 600,000 - - Stock Option (right to buy)
Arthur Santora Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Sep 2022 20,000 20,000 - - Stock Option (right to buy)
Dana Yaacov-Garbeli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Sep 2022 35,000 35,000 - - Stock Option (right to buy)
Sean Ellis Director Purchase of securities on an exchange or from another person at price $ 1.64 per share. 21 Jul 2022 14,900 32,100 (0%) 0% 1.6 24,406 Ordinary Shares, par value NIS 0.0000769 per share
Hillel Galitzer Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 60,000 60,000 - - Stock Option (right to buy)
Phillip Schwartz Director, President of R&D Purchase of securities on an exchange or from another person at price $ 2.52 per share. 20 Jan 2022 10,000 607,410 (5%) 0% 2.5 25,250 Ordinary Shares, par value NIS 0.0000769 per share
Ramesh Ratan U.S.based CFO Purchase of securities on an exchange or from another person at price $ 2.44 per share. 19 Jan 2022 10,000 10,000 (0%) 0% 2.4 24,364 Ordinary Shares, par value NIS 0.0000769 per share
Spiros Jamas Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.85 per share. 18 Jan 2022 10,000 10,000 (0%) 0% 2.9 28,500 Ordinary Shares, par value NIS 0.0000769 per share
Ron Mayron Director Purchase of securities on an exchange or from another person at price $ 2.80 per share. 18 Jan 2022 7,000 7,000 (0%) 0% 2.8 19,600 Ordinary Shares, par value NIS 0.0000769 per share
Miranda Jayne Toledano Director Purchase of securities on an exchange or from another person at price $ 2.79 per share. 14 Jan 2022 6,800 6,800 (0%) 0% 2.8 18,971 Ordinary Shares, par value NIS 0.0000769 per share
Gerald M. Ostrov Director Purchase of securities on an exchange or from another person at price $ 2.74 per share. 13 Jan 2022 10,000 10,000 (0%) 0% 2.7 27,378 Ordinary Shares, par value NIS 0.0000769 per share
Yonatan Malca Director Purchase of securities on an exchange or from another person at price $ 2.74 per share. 13 Jan 2022 7,232 7,232 (0%) 0% 2.7 19,816 Ordinary Shares, par value NIS 0.0000769 per share
Sean Ellis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 35,852 35,852 - - Stock Option (right to buy)
Roger J. Garceau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 35,852 35,852 - - Stock Option (right to buy)
Roger J. Garceau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 107,557 107,557 - - Stock Option (right to buy)
Gerald M. Ostrov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 107,557 107,557 - - Stock Option (right to buy)
Gerald M. Ostrov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 35,852 35,852 - - Stock Option (right to buy)
Miranda Jayne Toledano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 35,852 35,852 - - Stock Option (right to buy)
Miranda Jayne Toledano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 107,557 107,557 - - Stock Option (right to buy)
Yonatan Malca Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 107,557 107,557 - - Stock Option (right to buy)
Yonatan Malca Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 35,852 35,852 - - Stock Option (right to buy)
Ron Mayron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 35,852 35,852 - - Stock Option (right to buy)
Ron Mayron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 107,557 107,557 - - Stock Option (right to buy)
Sean Ellis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 107,557 107,557 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters